UBS Maintains Buy on UnitedHealth Group, Raises Price Target to $680
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Kevin Caliendo maintains a Buy rating on UnitedHealth Group (NYSE:UNH) and raises the price target from $640 to $680.
July 18, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
UBS analyst Kevin Caliendo maintains a Buy rating on UnitedHealth Group and raises the price target from $640 to $680.
The Buy rating and increased price target from a reputable analyst at UBS is likely to positively influence investor sentiment and drive short-term price appreciation for UnitedHealth Group.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100